the Department of Health and Hospitals to conduct a study on access to psychiatric medications and the costs for nonaccess to such medications.
Impact
The potential impact of SCR132 on state laws primarily revolves around its call for a thorough analysis of how access to psychiatric medications affects compliance rates among mental health patients. The resolution specifically notes that many patients do not adhere to their prescribed medications due to various factors, including a lack of understanding and inconsistent access. This situation could lead to serious consequences, including hospitalization, incarceration, and loss of productivity, suggesting a need for strategic changes in how mental health care is provided and financed within Louisiana's healthcare structure.
Summary
SCR132 is a Senate Concurrent Resolution that urges and requests the Louisiana Department of Health and Hospitals to conduct a study regarding access to psychiatric medications and the associated costs when such access is not available. The resolution highlights significant statistics, presenting that over 42 million adults in the U.S. experienced mental illness in 2012, with Louisiana having a higher prevalence rate compared to the national average. This fact underscores the urgent need for addressing mental health care in the state, especially as changes in Medicaid managed care are expected to reshape the current landscape for providing these services.
Sentiment
The sentiment surrounding SCR132 appears to be generally supportive among lawmakers, as evidenced by the substantial favorable vote it received (90 yeas to 1 nay). This strong backing indicates broad recognition of the challenges faced by individuals with mental health conditions in accessing necessary medications. However, some concerns likely exist regarding the feasibility of implementing any recommended changes from the forthcoming study, particularly in light of the complexities tied to Medicaid reform and mental health policies.
Contention
Notable points of contention surrounding SCR132 may arise when discussing the implications of the study's findings on existing policies and funding. While the resolution aims to identify gaps in care, the solutions suggested may lead to debates on resource allocation, with stakeholders potentially opposing changes that might require additional funding or adjustments to healthcare delivery models. The resolution does not change laws directly but acts as a catalyst for further exploration of the issue, setting the stage for potential legislative proposals based on the outcomes of the study.
Requests the Department of Health and Hospitals to study the most effective means to ensure the proper utilization of Attention Deficit Hyperactivity Disorder medications in Louisiana and to report its findings to the legislature.
Directs the Department of Health and Hospitals to evaluate and report on the number of Bayou Health plans that are necessary and appropriate before releasing another RFP to procure such plans.
Requests the State Licensing Board for Contractors and the Department of Health and Hospitals, office of public health, to study the lack of availability of inspectors to timely complete inspections involved in construction projects.
Directs the Department of Health and Hospitals to evaluate and report on the health benefits and costs of adding Krabbe disease to the list of mandatory screenings performed on newborns under certain circumstances.
Requests the Department of Health and Hospitals to submit a report by October 1, 2016, and to add Adrenoleukodystrophy (ALD) to the newborn screening panel no later than August 1, 2017.
Directs the Louisiana Department of Health to evaluate the current standards for psychiatric hospitals and residential substance abuse facilities and make recommendations to the legislature